While the reauthorization of PDUFA was the focal point of a House subcommittee hearing Wednesday, lawmakers also began consideration of two acts that require and incentivize pediatric drug trials.
In the opening congressional hearing to reauthorize PDUFA, the discussion Wednesday ranged from the dangers of the Brazilian Blowout hair straightener to the Tobacco Control Act.
WASHINGTON – Recognizing social media as a powerful tool that small start-ups can use to attract investors, an SEC advisory committee is advising the commission to consider an exemption from its registration requirements to permit crowd-funding.
WASHINGTON – After coming under fire for delaying rulemaking on prescription drug reimbursement, the Centers for Medicare & Medicaid Services (CMS) has proposed a rule to implement provisions of the 2010 Affordable Care Act (ACA) relating to manufacturer rebates and alignment of pharmacy reimbursement rates for covered outpatient prescription drugs.
WASHINGTON – All those drug ads on TV may eventually be required to include side-effect and contraindication information in superimposed text as well as audio.
In an economy gasping for air, patents are increasingly becoming the oxygen of biopharma, fueling a litigation process that fans their value even more.
